Characterization of the regulation of renal Na<sup>+</sup>/H<sup>+</sup>exchanger NHE3 by insulin
Daniel G. Fuster(University of Bern), Orson W. Moe(Io Therapeutics (United States)), I. Alexandru Bobulescu(Southwestern Medical Center), Jianning Zhang(The University of Texas Southwestern Medical Center), James B. Wade(University of Maryland, Baltimore)
Cited by 119
Related Papers
Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy
|The Lancet|2017|923
Hyperuricemia, Acute and Chronic Kidney Disease, Hypertension, and Cardiovascular Disease: Report of a Scientific Workshop Organized by the National Kidney Foundation
|American Journal of Kidney Diseases|2018|644
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|509
Renal Transport of Uric Acid: Evolving Concepts and Uncertainties
|Advances in Chronic Kidney Disease|2012|394
Pathophysiologic basis for normouricosuric uric acid nephrolithiasis
|Kidney International|2002|346